Cell Reports logo

Paper of the Week

N-Glycanase 1 Transcriptionally Regulates Aquaporins Independent of Its Enzymatic Activity

Scientist Robert Wechsler-Reya of Sanford Burnham Prebys and Rady Children’s Institute for Genomic Medicine, clinician John Crawford of Rady Children’s Hospital–San Diego, pediatric brain cancer survivor Travis Selinka, patient advocate Lynne Selinka, and patient advocate Tony Selinka
l-r: Scientist Robert Wechsler-Reya of SBP and Rady Children’s Institute for Genomic Medicine, clinician John Crawford of Rady Children’s Hospital–San Diego, pediatric brain cancer survivor Travis Selinka, patient advocates Lynne and Tony Selinka

Blog

How to help children survive—and thrive—after a brain cancer diagnosis

Pediatric brain tumor experts gather at the Fleet Science Center to discuss paths to better treatments.
Brooke Emerling, Ph.D., headshot

Blog

Prestigious Forbeck Scholar Award granted to Sanford Burnham Prebys cancer researcher

This prestigious award recognizes early-career cancer researchers for their achievements, research and dedication to the field.
FierceBiotech logo

In the News

A new strategy for boosting PD-1 blockers in melanoma

Sanford Burnham Prebys researchers sensitized melanoma to PD-1 blockade by inhibiting a protein called Siah2 in mouse models of the disease.
3D illustration of T cells attacking a cancer cell (CAR-T cell therapy)

Press Release

Study reveals a new approach to enhancing response to immunotherapy in melanoma

Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified a new way to boost the immune system’s ability to fight cancer.

Sanford Burnham Prebys Newsletter

Subscribe to our monthly email newsletter Discoveries.

 

Connect with us

Follow us on social media for the latest from Sanford Burnham Prebys.